Ralph E. Cutler

3.8k total citations · 1 hit paper
80 papers, 3.0k citations indexed

About

Ralph E. Cutler is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ralph E. Cutler has authored 80 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 20 papers in Pulmonary and Respiratory Medicine and 18 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ralph E. Cutler's work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Electrolyte and hormonal disorders (9 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Ralph E. Cutler is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (17 papers), Electrolyte and hormonal disorders (9 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Ralph E. Cutler collaborates with scholars based in United States, Canada and Germany. Ralph E. Cutler's co-authors include Andrew D. Blair, Gary E. Striker, Earl P. Benditt, René H. Levy, Robert Gutman, Arden W. Forrey, Bruce C. Gilliland, A. W. Forrey, Ellen Burgess and Jovan Milutinovic and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Ralph E. Cutler

80 papers receiving 2.7k citations

Hit Papers

Structural-functional correlations in renal disease 1970 2026 1988 2007 1970 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph E. Cutler United States 32 767 617 568 485 459 80 3.0k
Gert A. Verpooten Belgium 34 895 1.2× 361 0.6× 506 0.9× 616 1.3× 515 1.1× 107 4.1k
AM Breckenridge United Kingdom 47 229 0.3× 282 0.5× 1.1k 1.9× 564 1.2× 862 1.9× 157 5.8k
Micha Levy Israel 31 461 0.6× 207 0.3× 404 0.7× 1.4k 2.8× 494 1.1× 51 3.5k
L. Arisz Netherlands 39 2.7k 3.5× 807 1.3× 357 0.6× 310 0.6× 319 0.7× 130 4.4k
Hassane Izzedine France 31 612 0.8× 722 1.2× 331 0.6× 816 1.7× 198 0.4× 103 4.1k
Richard A. Robson New Zealand 29 348 0.5× 173 0.3× 270 0.5× 480 1.0× 330 0.7× 87 2.8k
Michele Mussap Italy 35 1.1k 1.4× 625 1.0× 488 0.9× 828 1.7× 220 0.5× 169 4.5k
Todd W.B. Gehr United States 36 1.0k 1.3× 604 1.0× 182 0.3× 894 1.8× 223 0.5× 105 3.4k
Lynda Frassetto United States 37 1.8k 2.4× 301 0.5× 522 0.9× 849 1.8× 181 0.4× 108 4.8k
W Guder Germany 31 610 0.8× 295 0.5× 511 0.9× 1.2k 2.6× 122 0.3× 128 3.6k

Countries citing papers authored by Ralph E. Cutler

Since Specialization
Citations

This map shows the geographic impact of Ralph E. Cutler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph E. Cutler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph E. Cutler more than expected).

Fields of papers citing papers by Ralph E. Cutler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph E. Cutler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph E. Cutler. The network helps show where Ralph E. Cutler may publish in the future.

Co-authorship network of co-authors of Ralph E. Cutler

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph E. Cutler. A scholar is included among the top collaborators of Ralph E. Cutler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph E. Cutler. Ralph E. Cutler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cutler, Ralph E.. (1997). Mammalian Raf-1 is activated by mutations that restore Raf signaling in Drosophila. The EMBO Journal. 16(8). 1953–1960. 16 indexed citations
3.
Wechter, William J., et al.. (1996). Human Plasma Concentrations of R, S, and Racemic Flurbiprofen Given as a Toothpaste. The Journal of Clinical Pharmacology. 36(6). 546–553. 6 indexed citations
4.
Cutler, Ralph E., Evelyn T. Maizels, & Mary Hunzicker-Dunn. (1994). Delta protein kinase-C in the rat ovary: estrogen regulation and localization.. Endocrinology. 135(4). 1669–1678. 37 indexed citations
5.
Cutler, Ralph E., et al.. (1991). Comparison of the Steady-State Pharmacokinetics of Fosinopril, Lisinopril and Enalapril in Patients with Chronic Renal Insufficiency. Clinical Pharmacokinetics. 20(5). 420–427. 60 indexed citations
6.
Holtzman, Jordan L., et al.. (1990). Multicenter comparison of once- and twice-daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patients. Clinical Pharmacology & Therapeutics. 48(5). 590–597. 4 indexed citations
7.
Cutler, Ralph E., et al.. (1990). Apparent Reduced Absorption of Gemfibrozil When Given with Colestipol. The Journal of Clinical Pharmacology. 30(1). 29–32. 20 indexed citations
8.
Sandborn, William J., et al.. (1990). Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Cimetidine in Seriously III Patients. The Journal of Clinical Pharmacology. 30(6). 568–571. 5 indexed citations
9.
Burgess, Ellen, Andrew D. Blair, Ralph E. Cutler, et al.. (1988). Oral Flecainide Pharmacokinetics in Patients with Impaired Renal Function. The Journal of Clinical Pharmacology. 28(3). 259–267. 24 indexed citations
10.
Chandler, Mary H.H., Horst Schran, Ralph E. Cutler, et al.. (1988). The Effects of Renal Function on the Disposition of Isradipine. The Journal of Clinical Pharmacology. 28(12). 1076–1080. 16 indexed citations
11.
Evans, John R., et al.. (1988). Pharmacokinetics of Iothalamate in Endstage Renal Disease. The Journal of Clinical Pharmacology. 28(9). 826–830. 14 indexed citations
12.
Cutler, Ralph E., et al.. (1988). Flecainide Pharmacokinetics After Multiple Dosing in Patients with Impaired Renal Function. The Journal of Clinical Pharmacology. 28(8). 727–735. 17 indexed citations
13.
Winer, Robert L., Ralph E. Cutler, Allen I. Arieff, et al.. (1987). Effects of a Magnesium-Free Dialysate on Magnesium Metabolism During Continuous Ambulatory Peritoneal Dialysis. American Journal of Kidney Diseases. 10(4). 268–275. 14 indexed citations
14.
Evans, John R., et al.. (1987). The Effect of Renal Function on the Pharmacokinetics of Gemfibrozil. The Journal of Clinical Pharmacology. 27(12). 994–1000. 23 indexed citations
15.
Blair, Andrew D., et al.. (1984). Cefonicid kinetics in subjects with normal and impaired renal function. Clinical Pharmacology & Therapeutics. 35(6). 798–803. 13 indexed citations
16.
Stothert, Joseph C., David Simonowitz, E. Patchen Dellinger, et al.. (1980). Randomized Prospective Evaluation of Cimetidine and Antacid Control of Gastric pH in the Critically III. Annals of Surgery. 192(2). 169–174. 92 indexed citations
17.
Cutler, Ralph E. & Andrew D. Blair. (1979). Clinical Pharmacokinetics of Frusemide. Clinical Pharmacokinetics. 4(4). 279–296. 77 indexed citations
18.
Blair, Andrew D., et al.. (1977). Effects of probenecid on furosemide kinetics and natriuresis in man. Clinical Pharmacology & Therapeutics. 22(4). 395–401. 57 indexed citations
19.
Milutinovic, Jovan, et al.. (1975). Measurement of residual glomerular filtration rate in the patient receiving repetitive hemodialysis. Kidney International. 8(3). 185–190. 108 indexed citations
20.
Cutler, Ralph E.. (1972). Correlation of Serum Creatinine Concentration and Gentamicin Half-Life. JAMA. 219(8). 1037–1037. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026